To The Moon

$Rigetti Computing(RGTI)$ is on a nice uptrend! The key level to watch is a solid break above $46. If that happens, the next price target could be in the $49-$55 range. Plenty of room to run, staying bullish!

$Circle Internet Corp.(CRCL)$ Scarcity & compliance are key edges. Circle's network stays strong: USDC volume 5.4x YoY, CCTP up 4.1x — blockchain interoperability is clearly crucial!

$BigBear.ai Holdings(BBAI)$ As of Aug 4, institutional holdings reached 29.8%, up 5.3 percentage points from Jul 21. Trading volume has stabilized recently with noticeably improved concentration, maintaining a positive outlook.

$Robinhood(HOOD)$ didn't disappoint this time! The zero-commission broker is regaining attention as rate hikes wind down, with its newly launched retirement accounts gaining traction. Their innovation potential remains promising - holding for next quarter's user growth metrics!

CARsgen-B(02171) up 8% today, strong move! Biotech’s entering a shakeout phase, and when the sector diverges, true leaders shine. CARsgen looks like it’s leading the charge, could have more room to run!

$BABA-W(09988)$ didn’t just invest in Meitu for its potential, it’s also likely a smart hedge against its collaboration with $Apple(AAPL)$ . At the heart of it lies one key factor: artificial intelligence. Meitu’s strength in vertical AI applications, especially in imaging and design, clearly stood out. That’s what convinced Alibaba to back it with serious capital, helping push forward costly R&D in large models. Meanwhile, tools like Meitu Design Studio align perfectly with Alibaba’s push to improve merchant services on its e-commerce platforms. This partnership looks like a well-calculated win-win move with strategic alignment on both sides.

$MINISO Group Holding Limited(MNSO)$ ’s been buying back shares like crazy lately, and that definitely got my attention. I listened to a few speeches by Ye Guofu gotta say, he makes sense. This whole “quality-first” strategy sounds solid to me. At this price, it’s honestly hard to resist. So yeah… I added more. Not financial advice, but personally, I’m feeling pretty bullish. Feels like one of those hidden gems that’s just waiting to shine!

$HUTCHMED(00013)$ The biotech sector is experiencing a valuation re-rating, with industry leaders like HUTCHMED and $INNOVENT BIO(01801)$ leading the way. This year marks a turning point, not just for the broader Hong Kong stock market but also for innovative drugmakers. While much attention has been on Hang Seng Tech and Internet sectors, the Hong Kong Biotech ETF (SZ159570) has surged 32% year-to-date, significantly outperforming tech and internet ETFs. Positive catalysts such as improving drug procurement policies, booming License out deals from major players like Hengrui, and Innovent’s stellar earnings report have fueled this rally. With Hong Kong-listed biotech stocks showing stronger rebounds due

$Zai Lab Ltd(ZLAB)$ Chinese healthcare stocks are looking promising this year, performing really well. Hong Kong stocks are also doing great. Keep it up!

$Palantir Technologies Inc.(PLTR)$ Palantir, a controversial tech stock, has silenced the skeptics with its stellar performance! Despite a sky-high P/E ratio of 304.47, it delivered an astonishing 293% return over the past year. The AI boom has unlocked limitless potential for this company, and the $50 SAR trigger is a testament to its bright future. Thanks to Wedbush and UBS analysts for shedding light on its AI dominance. This AI star stock remains on my watchlist!